Stericycle (NASDAQ:SRCL) Sees Strong Trading Volume

Stericycle, Inc. (NASDAQ:SRCL - Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 780,511 shares traded hands during mid-day trading, a decline of 28% from the previous session's volume of 1,076,847 shares.The stock last traded at $61.67 and had previously closed at $61.62.

Wall Street Analyst Weigh In

SRCL has been the subject of several analyst reports. Truist Financial upped their price target on Stericycle from $50.00 to $62.00 and gave the stock a "hold" rating in a research note on Tuesday, June 4th. StockNews.com assumed coverage on shares of Stericycle in a research note on Monday. They set a "hold" rating on the stock. Royal Bank of Canada restated a "sector perform" rating and issued a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods boosted their target price on Stericycle from $135.00 to $142.00 and gave the stock an "outperform" rating in a research report on Tuesday, June 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $74.00.

Stericycle Trading Up 0.1 %

The firm has a market cap of $5.73 billion, a price-to-earnings ratio of -280.41, a PEG ratio of 3.36 and a beta of 1.11. The business has a fifty day moving average of $58.80 and a two-hundred day moving average of $54.37. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13.

Stericycle (NASDAQ:SRCL - Get Free Report) last issued its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, topping analysts' consensus estimates of $0.57 by $0.04. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. The business had revenue of $661.60 million during the quarter, compared to the consensus estimate of $672.07 million. As a group, equities analysts expect that Stericycle, Inc. will post 2.29 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Stericycle

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Clearstead Trust LLC acquired a new stake in shares of Stericycle in the first quarter valued at about $25,000. International Assets Investment Management LLC purchased a new position in shares of Stericycle in the second quarter valued at $45,000. GAMMA Investing LLC grew its holdings in Stericycle by 170.9% during the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider's stock valued at $43,000 after purchasing an additional 516 shares in the last quarter. Principal Securities Inc. purchased a new stake in Stericycle during the 4th quarter worth $41,000. Finally, Headlands Technologies LLC acquired a new position in Stericycle in the 1st quarter worth $44,000. 98.82% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.